The myeloproliferative disorders and their treatment with interferon alfa

被引：0
|
作者：
Silver, RT
机构：
来源：
MOLECULAR BIOLOGY OF HEMATOPOIESIS 5 | 1996年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：571 / 576
页数：6
相关论文
共 50 条
  • [31] Treatment paradigms in the management of myeloproliferative disorders
    Fruchtman, SM
    SEMINARS IN HEMATOLOGY, 2004, 41 (02) : 18 - 22
  • [32] Chronic myeloproliferative disorders: diagnosis and treatment
    Lengfelder, E
    Berger, U
    Reiter, A
    Hochhaus, A
    Hehlmann, R
    INTERNIST, 2003, 44 (08): : 1011 - +
  • [33] Subcutaneous Interferon Alfa for the Treatment of Cutaneous Pseudolymphoma
    Singletary, Holly Leigh
    Selim, M. Angelica
    Olsen, Elise
    ARCHIVES OF DERMATOLOGY, 2012, 148 (05) : 572 - 574
  • [34] NATURAL INTERFERON ALFA FOR TREATMENT OF CONDYLOMATA ACUMINATA
    FRIEDMANKIEN, AE
    ERON, LJ
    CONANT, M
    GROWDON, W
    BADIAK, H
    BRADSTREET, PW
    FEDORCZYK, D
    TROUT, JR
    PLASSE, TF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (04): : 533 - 538
  • [35] Mania induced by withdrawal of treatment with interferon alfa
    Carpiniello, B
    Orrù, MG
    Baita, A
    Pariante, CM
    Farci, G
    ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (01) : 88 - 89
  • [36] RHABDOMYOLYSIS AFTER TREATMENT WITH INTERFERON-ALFA
    GREENFIELD, SM
    HARVEY, RS
    THOMPSON, RPH
    BRITISH MEDICAL JOURNAL, 1994, 309 (6953): : 512 - 512
  • [37] The role of interferon alfa in the treatment of metastatic melanoma
    Legha, SS
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S24 - S31
  • [38] MORPHOLOGICAL-CHANGES OF MEGAKARYOCYTES DURING INTERFERON TREATMENT OF CHRONIC MYELOPROLIFERATIVE DISORDERS WITH EXCESSIVE THROMBOCYTOSIS (CMPDWET)
    CHOTT, A
    THIELE, J
    GISSLINGER, H
    LINKESCH, W
    FRITZ, E
    RADASZKIEWICZ, T
    LUDWIG, H
    BLUT, 1988, 57 (04): : 231 - 231
  • [39] Influence of interferon-alpha on cytokine expression by the bone marrow microenvironment - Impact on treatment of myeloproliferative disorders
    Peschel, C
    Aulitzky, WE
    Huber, C
    LEUKEMIA & LYMPHOMA, 1996, 22 : 129 - 134
  • [40] Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases
    Melikyan, A. L.
    Subortseva, I. N.
    Gilyazitdinova, E. A.
    Koloshejnova, T. I.
    Pustovaya, E. I.
    Egorova, E. K.
    Kovrigina, A. M.
    Sudarikov, A. B.
    Abdullaev, A. O.
    Lomaia, E. G.
    Siordiya, N. T.
    Zaritskey, A. Yu.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (07) : 23 - 29
12345